296 related articles for article (PubMed ID: 20374430)
1. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
[TBL] [Abstract][Full Text] [Related]
2. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
5. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.
Li Y; Wu KJ; Yu SJ; Tamargo IA; Wang Y; Greig NH
Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.
Sharma MK; Jalewa J; Hölscher C
J Neurochem; 2014 Feb; 128(3):459-71. PubMed ID: 24112036
[TBL] [Abstract][Full Text] [Related]
9. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats.
Xie Z; Enkhjargal B; Wu L; Zhou K; Sun C; Hu X; Gospodarev V; Tang J; You C; Zhang JH
Neuropharmacology; 2018 Jan; 128():142-151. PubMed ID: 28986282
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.
Cunha DA; Ladrière L; Ortis F; Igoillo-Esteve M; Gurzov EN; Lupi R; Marchetti P; Eizirik DL; Cnop M
Diabetes; 2009 Dec; 58(12):2851-62. PubMed ID: 19720788
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
14. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.
Li XN; Bu HM; Ma XH; Lu S; Zhao S; Cui YL; Sun J
Exp Clin Endocrinol Diabetes; 2017 Feb; 125(2):91-97. PubMed ID: 28008585
[No Abstract] [Full Text] [Related]
17. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes.
Mangmool S; Hemplueksa P; Parichatikanond W; Chattipakorn N
Mol Endocrinol; 2015 Apr; 29(4):583-96. PubMed ID: 25719403
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.
Fan Y; Liu K; Wang Q; Ruan Y; Zhang Y; Ye W
Mol Vis; 2014; 20():1557-68. PubMed ID: 25489228
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity.
Kim JY; Lim DM; Moon CI; Jo KJ; Lee SK; Baik HW; Lee KH; Lee KW; Park KY; Kim BJ
J Korean Med Sci; 2010 Nov; 25(11):1626-32. PubMed ID: 21060752
[TBL] [Abstract][Full Text] [Related]
20. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]